Cardiff Oncology, Inc.
CRDF· Nasdaq
CRDFCardiff Oncology, Inc.
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001104659-12-037472
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $34.00K | $89.08K |
| Net Income | -$1.16M | -$551.99K |
| EPS Diluted | -$0.11 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end
